<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00222378</url>
  </required_header>
  <id_info>
    <org_study_id>20043510</org_study_id>
    <secondary_id>Protocol VAL094</secondary_id>
    <secondary_id>WIRB® Protocol #20050561</secondary_id>
    <nct_id>NCT00222378</nct_id>
  </id_info>
  <brief_title>Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease</brief_title>
  <official_title>Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hoffmann-La Roche</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An increase prevalence of CMV, EBV and or HHV-6 in diseased tissue of inflammatory bowel
      disease would suggest a role for these viruses in the etiology and/or exacerbation of IBD,
      whereas their absence would preclude such association.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protocol is designed to evaluate the following objectives:

        1. The prevalence of cytomegalovirus, Epstein Barr virus and human herpes 6 virus DNA in
           inflamed intestinal mucosa of patients with Crohn's colitis and ulcerative colitis
           compared to their prevalence in healthy intestinal mucosa of patients not affected by
           these conditions;

        2. To evaluate the prevalence of cytomegalovirus, Epstein Barr virus and human herpes 6
           virus DNA in the intestinal mucosa of patients with Crohn's colitis and ulcerative
           colitis compared to that in inflamed mucosa caused by other conditions (non specific
           colitis);

        3. To compare the prevalence of cytomegalovirus, Epstein Barr virus and human herpes 6
           virus DNA in inflamed and healthy tissue in the same patients with Crohn's colitis and
           ulcerative colitis;

        4. To determine whether the presence of cytomegalovirus, Epstein Barr virus and human
           herpes 6 virus DNA detected by nPCR correlates with immunohistochemical detection of
           viral protein in colonic tissue.

        5. To determine whether the relative viral quantity of CMV, EBV or HHV-6 is related to
           severity of disease activity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Cytomegalovirus and Epstein Barr Virus in Patients with Mild to Moderate Inflammatory Bowel Disease compared to patients without inflammatory bowel disease</measure>
    <time_frame>0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of Cytomegalovirus and Epstein Barr Virus in inflamed colonic tissue versus non inflamed tissues from Patients with Mild to Moderate Inflammatory.</measure>
    <time_frame>0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of Cytomegalovirus and Epstein Barr Virus in inflamed colonic tissue from patient with mild to moderate IBD as compared to inflamed mucosa from patients with other inflammatory diseases of the colon</measure>
    <time_frame>0</time_frame>
  </primary_outcome>
  <enrollment type="Actual">129</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Specimens will be discarded upon study completion
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with inflammatory bowel disease (ulcerative colitis and Crohn's Colitis), Other
        inflammatory conditions of the colon
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented, signed and dated informed consent to participate in this trial prior to
             any study related procedures being performed.

          -  Participants, male or female, aged 18-70, identified as having Crohn's colitis, UC and
             patients undergoing biopsy for other inflammatory disorders (non specific colitis) and
             for suspected intestinal malignancy.

        Exclusion Criteria:

          -  Known human immunodeficiency virus (HIV) infection

          -  Post organ transplant patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey B Raskin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wakefield AJ, Fox JD, Sawyerr AM, Taylor JE, Sweenie CH, Smith M, Emery VC, Hudson M, Tedder RS, Pounder RE. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol. 1992 Nov;38(3):183-90.</citation>
    <PMID>1287131</PMID>
  </reference>
  <reference>
    <citation>Berk T, Gordon SJ, Choi HY, Cooper HS. Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol. 1985 May;80(5):355-60.</citation>
    <PMID>2859801</PMID>
  </reference>
  <reference>
    <citation>el-Serag HB, Zwas FR, Cirillo NW, Eisen RN. Fulminant herpes colitis in a patient with Crohn's disease. J Clin Gastroenterol. 1996 Apr;22(3):220-3. Review.</citation>
    <PMID>8724263</PMID>
  </reference>
  <reference>
    <citation>Caserta L, Riegler G. Cytomegalovirus and herpes simplex virus antibodies in patients with idiopathic ulcerative colitis. Am J Gastroenterol. 2001 Oct;96(10):3036-7.</citation>
    <PMID>11693350</PMID>
  </reference>
  <reference>
    <citation>Riegler G, Piscitelli A, Di Simone A, Esposito C, Sodano G, Tarro G. [Cytomegalovirus and herpes simplex virus antibodies in patients with idiopathic ulcerative rectocolitis]. Minerva Med. 1990 Dec;81(12):861-4. Italian.</citation>
    <PMID>2177863</PMID>
  </reference>
  <reference>
    <citation>Cooper HS, Raffensperger EC, Jonas L, Fitts WT Jr. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology. 1977 Jun;72(6):1253-6.</citation>
    <PMID>192627</PMID>
  </reference>
  <reference>
    <citation>Sidi S, Graham JH, Razvi SA, Banks PA. Cytomegalovirus infection of the colon associated with ulcerative colitis. Arch Surg. 1979 Jul;114(7):857-9.</citation>
    <PMID>222233</PMID>
  </reference>
  <reference>
    <citation>Cottone M, Pietrosi G, Martorana G, Casà A, Pecoraro G, Oliva L, Orlando A, Rosselli M, Rizzo A, Pagliaro L. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001 Mar;96(3):773-5.</citation>
    <PMID>11280549</PMID>
  </reference>
  <reference>
    <citation>Adani GL, Avital I, Ferraresso C, Aoki T. CMV infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001 Dec;96(12):3464-5.</citation>
    <PMID>11774988</PMID>
  </reference>
  <reference>
    <citation>Wada Y, Matsui T, Matake H, Sakurai T, Yamamoto J, Kikuchi Y, Yorioka M, Tsuda S, Yao T, Yao S, Haraoka S, Iwashita A. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum. 2003 Oct;46(10 Suppl):S59-65.</citation>
    <PMID>14530660</PMID>
  </reference>
  <reference>
    <citation>Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004 Mar;28(3):365-73.</citation>
    <PMID>15104299</PMID>
  </reference>
  <reference>
    <citation>Probert CS, Hearing SD, Schreiber S, Kühbacher T, Ghosh S, Arnott ID, Forbes A. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut. 2003 Jul;52(7):998-1002.</citation>
    <PMID>12801957</PMID>
  </reference>
  <reference>
    <citation>Bertalot G, Villanacci V, Gramegna M, Orvieto E, Negrini R, Saleri A, Terraroli C, Ravelli P, Cestari R, Viale G. Evidence of Epstein-Barr virus infection in ulcerative colitis. Dig Liver Dis. 2001 Oct;33(7):551-8.</citation>
    <PMID>11816543</PMID>
  </reference>
  <reference>
    <citation>Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol. 2000 Jul;157(1):51-7.</citation>
    <PMID>10880375</PMID>
  </reference>
  <reference>
    <citation>Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K. Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterol. 1999 Jun;94(6):1582-6.</citation>
    <PMID>10364028</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>July 28, 2015</last_update_submitted>
  <last_update_submitted_qc>July 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Paul Feldman</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Crohn's disease</keyword>
  <keyword>ulcerative colitis</keyword>
  <keyword>cytomegalovirus</keyword>
  <keyword>Epstein Bar Virus</keyword>
  <keyword>Human Herpes virus 6</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

